Evidence mapPaperPMID 38728303Full record

ArticlePloS one2024

Nutritional, molecular, and functional properties of a novel enzymatically hydrolyzed porcine plasma product.

Marc Solà-Ginés, Lluïsa Miró, Aina Bellver-Sanchis, Christian Griñán-Ferré, Mercè Pallàs, Anna Pérez-Bosque, Miquel Moretó, Laura Pont, Fernando Benavente, José Barbosa and 2 more

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Marc Solà-GinésAPC Europe S.L.U., Granollers, Spain.ORCID https://orcid.org/0009-0007-9962-3433
Lluïsa MiróAPC Europe S.L.U., Granollers, Spain.
Aina Bellver-SanchisDepartament de Farmacologia, Toxicologia i Química Terapèutica (Secció de Farmacologia) Facultat de Farmàcia i Ciències de l'Alimentació and Institut de Neurociències (CIBERNED), Universitat de Barcelona, Barcelona, Spain.
Christian Griñán-FerréDepartament de Farmacologia, Toxicologia i Química Terapèutica (Secció de Farmacologia) Facultat de Farmàcia i Ciències de l'Alimentació and Institut de Neurociències (CIBERNED), Universitat de Barcelona, Barcelona, Spain.
Mercè PallàsDepartament de Farmacologia, Toxicologia i Química Terapèutica (Secció de Farmacologia) Facultat de Farmàcia i Ciències de l'Alimentació and Institut de Neurociències (CIBERNED), Universitat de Barcelona, Barcelona, Spain.
Anna Pérez-BosqueDepartament de Bioquímica i Fisiologia (Secció de Fisiologia), Facultat de Farmàcia i Ciències de l'Alimentació and Institut de Nutrició i Seguretat Alimentària, Universitat de Barcelona (INSA·UB), Barcelona, Spain.
Miquel MoretóDepartament de Bioquímica i Fisiologia (Secció de Fisiologia), Facultat de Farmàcia i Ciències de l'Alimentació and Institut de Nutrició i Seguretat Alimentària, Universitat de Barcelona (INSA·UB), Barcelona, Spain.
Laura PontDepartment of Chemical Engineering and Analytical Chemistry, Institute for Research on Nutrition and Food Safety (INSA·UB), University of Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0003-0520-0450
Fernando BenaventeSerra Húnter Programe, Generalitat de Catalunya, Barcelona, Spain.
José BarbosaSerra Húnter Programe, Generalitat de Catalunya, Barcelona, Spain.
Carmen RodríguezAPC Europe S.L.U., Granollers, Spain.
Javier PoloAPC Europe S.L.U., Granollers, Spain.ORCID https://orcid.org/0000-0003-0990-2230

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the present study, an enzymatically hydrolyzed porcine plasma (EHPP) was nutritionally and molecularly characterized. EHPP molecular characterization showed, in contrast to spray-dried plasma (SDP), many peptides with relative molecular masses (Mr) below 8,000, constituting 73% of the protein relative abundance. IIAPPER, a well-known bioactive peptide with anti-inflammatory and antioxidant properties, was identified. In vivo functionality of EHPP was tested in C. elegans and two different mouse models of intestinal inflammation. In C. elegans subjected to lipopolysaccharide exposure, EHPP displayed a substantial anti-inflammatory effect, enhancing survival and motility by 40% and 21.5%, respectively. Similarly, in mice challenged with Staphylococcus aureus enterotoxin B or Escherichia coli O42, EHPP and SDP supplementation (8%) increased body weight and average daily gain while reducing the percentage of regulatory Th lymphocytes. Furthermore, both products mitigated the increase of pro-inflammatory cytokines expression associated with these challenged mouse models. In contrast, some significant differences were observed in markers such as Il-6 and Tnf-α, suggesting that the products may present different action mechanisms. In conclusion, EHPP demonstrated similar beneficial health effects to SDP, potentially attributable to the immunomodulatory and antioxidant activity of its characteristic low Mr bioactive peptides.

Indexed as

Caenorhabditis elegansAnimalsAnti-Inflammatory AgentsAntioxidantsCytokinesHydrolysisLipopolysaccharidesMicePlasmaSwineAnti-Inflammatory AgentsAntioxidantsCytokinesLipopolysaccharides

Identifiers

PMID38728303
PMCPMC11086891

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.